Presenter: A. Kinga Malinowski MD
Dr. A. Kinga Malinowski completed her fellowship in Maternal-Fetal Medicine at Mount Sinai Hospital, Toronto. Since joining the Maternal-Fetal Medicine Division at Mount Sinai Hospital in 2011, her clinical activity has focused on haematologic conditions affecting pregnancy. She is Co-Director of the Hematology in Pregnancy Program. Dr. Malinowski also holds the position of Clinician Investigator at Mount Sinai Hospital and the Lunenfeld-Tanenbaum Research Institute, with a cross-appointment at the rank of Assistant Professor at the University of Toronto.
Thematically, her research interests parallel her clinical focus, with an emphasis on haematologic disorders in pregnancy, particularly as it relates to studies addressing the impact of Sickle Cell Disease on pregnancy outcomes. Concurrently, Dr. Malinowski has an interest in research standardization, pursuing the development of Core Outcome Sets for several haematologic disorders affecting pregnancy.
Presenter: Susan Huang MD
Dr. Huang is a clinician-researcher with an MD and a PhD in Medical Biophysics. She is an Assistant Professor at Western University. She completed her medical degree at the University of Ottawa and trained in the Internal Medicine residency and Nephrology Fellowship programs at Western University. Her research has attracted multiple peer-reviewed grant funding. She applies novel imaging techniques to study the pathophysiology of renal disease, complications of dialysis and thrombotic microangiopathy. She has authored over 60 manuscripts in the fields of nephrology and Thrombotic Thrombocytopenic Purpura (TTP) in prominent articles/reviews in high-impact journals, including JAMA, British Medical Journal, and Kidney International.
Presenter: Dr. Shruti Chaturvedi
Dr. Shruti Chaturvedi is an Assistant Professor of Medicine in the Division of Hematology at Johns Hopkins University School of Medicine. She received her medical degree from the University of Delhi in India and went on to complete a residency in Internal Medicine from the Cleveland Clinic and a fellowship in Hematology and Oncology from Vanderbilt University. During her fellowship, she also completed a Master of Science in Clinical Investigation, with a focus on genetic epidemiology. She has been supported by grants from the American Society of Hematology, the Hemostasis and Thrombosis Research Society and is a current recipient of the Johns Hopkins University Clinician Scientist Award. She has a clinic focused on the care of patients with thrombotic microangiopathies, and her research focus is also on thrombotic microangiopathy, particularly long-term complications, as well as the role of complement in other hematologic disorders, including the antiphospholipid syndrome and sickle cell disease.
Presenter: Dr. Joceyln Garland
Dr. Garland is an Associate Professor of Medicine and Nephrology at Queen's University, where she has worked since she began her career in academic medicine in 2003. She has consistently demonstrated an avid interest in excellence in clinical care, and a passion for medical education. Dr. Garland's teaching skills have been acknowledged by both undergraduate and post-graduate medical learners. More recently, Dr. Garland won the Queen's University Department of Medicine Clinical Teaching Award in 2016 and in 2017, was the recipient of the Ontario Renal Network/Cancer Care Ontario Provincial Human Touch Award, for which she was nominated by one of her patients. In September, 2018, she won the Royal College of Physicians and Surgeons of Canada Specialist of the Year award, for her work in a challenging thrombotic micro-angiopathy case.
A highly-respected clinician, Dr. Garland's nephrology practice specializes primarily in the area of rare kidney diseases. She also participates in collaborative research initiatives, including clinical practice guidelines, and clinical trials. She is Medical Director for the Glomerulonephritis (GN)/Pregnancy in Renal Disease clinic, and of Apheresis, at Kingston Health Sciences Centre (KHSC). The Ontario Renal Network has recognized KHSC's Glomerulonephritis clinic as one of six specialty GN clinics in the province.
Presenter: Dr. Ted Warkentin
Dr. Ted Warkentin is a hematologist and transfusion medicine director at Hamilton General Hospital, and is a Professor in the Department of Pathology and Molecular Medicine, and the Department of Medicine, at McMaster University, in Hamilton, Ontario, Canada. His research focuses on acquired thrombocytopenias and coagulopathies—most notably the topics of "heparin-induced thrombocytopenia (HIT)" and "ischemic limb gangrene with pulses."
He is a co-winner (with Prof. John Kelton) of the 2015 Prix Galien Canada Prize, the highest award for Canadian scientists who have made significant advances in pharmaceutical research. He has edited 5 editions of a book, Heparin-Induced Thrombocytopenia, has authored 102 book chapters and 357 peer-reviewed articles, and has given over 840 lectures international audiences."